The purpose of this thesis was to design new strategies to improve the patency of small diameter bypass grafts in the arte-rial circulation by reducing the formation of intimal hyperplasia. The following goals were formulated to evaluate the ef-ficacy of these new strategies: 1. To inventory the factors responsible for, and the strategies designed to control the formation of intimal hyperplasia in vein grafts in the arterial circulation. 2. To introduce a model to quantify early platelet and leucocyte deposition onto synthetic bypass grafts in vitro. 3. To evaluate the effect of periadventitial application of a sulfated carbohydrate polymer on the formation of intimal hy-perplasia in autologous vein graft in rab-bits. 4. To evaluate the e...
OBJECTIVES: Open arterial revascularization using venous segments is frequently associated with the ...
Open arterial revascularization using venous segments is frequently associated with the development ...
Vascular interventions for the treatment of symptomatic atherosclerosis fail in up to 40 % of the ca...
This thesis examines aspects of intimal hyperplasia in infrainguinal bypass grafts. There are 3 intr...
The most common cause of vein bypass graft failure in the postoperative period of 1 month to 1 year ...
Two novel strategies to improve the patency of vascular prostheses are described in this thesis. To ...
AbstractIn recent years, ample attention has been directed towards the mechanisms that play a major ...
Objectives: To use the autologous gastroepiploic artery (GEA) as arterial bypass graft for periphera...
Stenoses occur in 20-30% of infrainguinal vein bypass grafts, and are the commonest cause of graft f...
Examination of the changes in experimental autogenous vein grafts has presented some important resul...
Item does not contain fulltextIn recent years, ample attention has been directed towards the mechani...
Objectives:To use the autologous gastroepiploic artery (GEA) as arterial bypass graft for peripheral...
peer-reviewedObjective. Abnormal haemodynamics is commonly agreed to be a major contributor to the d...
Purpose: Intimal hyperplasia (IH) is a proliferative process of vascular smooth muscle cells that oc...
AbstractPurpose: The modification of the distal anastomosis of polytetrafluoroethylene (PTFE) bypass...
OBJECTIVES: Open arterial revascularization using venous segments is frequently associated with the ...
Open arterial revascularization using venous segments is frequently associated with the development ...
Vascular interventions for the treatment of symptomatic atherosclerosis fail in up to 40 % of the ca...
This thesis examines aspects of intimal hyperplasia in infrainguinal bypass grafts. There are 3 intr...
The most common cause of vein bypass graft failure in the postoperative period of 1 month to 1 year ...
Two novel strategies to improve the patency of vascular prostheses are described in this thesis. To ...
AbstractIn recent years, ample attention has been directed towards the mechanisms that play a major ...
Objectives: To use the autologous gastroepiploic artery (GEA) as arterial bypass graft for periphera...
Stenoses occur in 20-30% of infrainguinal vein bypass grafts, and are the commonest cause of graft f...
Examination of the changes in experimental autogenous vein grafts has presented some important resul...
Item does not contain fulltextIn recent years, ample attention has been directed towards the mechani...
Objectives:To use the autologous gastroepiploic artery (GEA) as arterial bypass graft for peripheral...
peer-reviewedObjective. Abnormal haemodynamics is commonly agreed to be a major contributor to the d...
Purpose: Intimal hyperplasia (IH) is a proliferative process of vascular smooth muscle cells that oc...
AbstractPurpose: The modification of the distal anastomosis of polytetrafluoroethylene (PTFE) bypass...
OBJECTIVES: Open arterial revascularization using venous segments is frequently associated with the ...
Open arterial revascularization using venous segments is frequently associated with the development ...
Vascular interventions for the treatment of symptomatic atherosclerosis fail in up to 40 % of the ca...